Organigram Global (OGI) Liabilities and Shareholders Equity (2018 - 2026)

Organigram Global (OGI) has reported Liabilities and Shareholders Equity for 9 consecutive years, with $380.1 million the latest figure, recorded in Q1 2026.

• In Q1 2026, Liabilities and Shareholders Equity changed N/A year-over-year to $380.1 million; the TTM figure through Mar 2026 stood at $1.2 billion (up 124.15% YoY), while the FY2025 annual figure was $380.5 million, changed N/A from the prior year.
• Liabilities and Shareholders Equity held at $380.1 million in Q1 2026 per OGI's latest filing, from $380.5 million in the prior quarter.
• Across five years, Liabilities and Shareholders Equity topped out at $448.1 million in Q3 2022 and bottomed at $222.6 million in Q3 2023.
• Historically, Liabilities and Shareholders Equity has averaged $356.5 million across 5 years, with a median of $380.3 million in 2025.
• Annual changes were most pronounced in 2022 — Liabilities and Shareholders Equity grew 0.55% — and 2025, when it jumped 36.64%.
• Organigram Global's Liabilities and Shareholders Equity stood at $448.1 million in 2022, then sank by 50.32% to $222.6 million in 2023, then jumped by 34.3% to $299.0 million in 2024, then gained by 27.28% to $380.5 million in 2025, then retreated by 0.1% to $380.1 million in 2026.
• Business Quant data shows OGI's Liabilities and Shareholders Equity at $380.1 million in Q1 2026, $380.5 million in Q4 2025, and $408.5 million in Q3 2025.